Beyond Serendipity: Unlocking Molecular Glue Discovery via AI and Automation
- As a promising next-gen proximity-induced therapy, molecular glues have great clinical and commercial value but face serendipitous discovery and technical bottlenecks; XtalPi solves these via a systematic platform combining physics-driven simulation, high-throughput tools and AI-powered VAST™ library, capable of predicting 60B compounds (4B+ synthesizable)
- The company’s technical platform demonstrates proven breakthrough value, capable of tackling challenging targets and achieving efficient optimization of lead compounds with structural support
- XtalPi boasts clear pipeline layout across multiple indications and mature commercial cooperation models, accelerating the translation of molecular glue technology from R&D to clinic and market